NVS: Novartis AG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NVS: Novartis AG

NVS 137.99

-0.5%

1:09 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Starlight who wrote (41)	5/30/2001 6:18:26 PM
From: aknahow	Read Replies (1) of 116

Betty, have never forgotten your help in the past years. Thanks for taking the time to explain how to cut and paste again and again. XOMA appears to be a much different situation than it was in the past. Xanelim might be on the market by 2003. Just a year and a half away. <g> Who knows what the FDA will do? But if it approves this DNA psoriasis drug XOMA should respond very well. While individuals were getting discouraged, among them the famous opalaprill, aka Mr. Opala, institutions were increasing their holdings from 2% to about 35% of outstanding shares.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next